
A world-first clinical trial for a fridge-free vaccine has been launched in the UK which could greatly increase access to jabs in the future.
The firm behind a vaccine that is completely stable at room temperature – the Stablepharma tetanus-diphtheria vaccine (SPVX02) – says up to 60 other vaccines may benefit from the advanced technology it uses.